Can Miravirsen Stop HCV with Little Side Effects?
Share
Follow Us
‘Sponge’ Drug Shows Promise For Treating Hepatitis C
by Michaeleen Doucleff
March 27, 2013
With an estimated 2 million baby boomers infected with hepatitis C, the disease has reached epidemic levels among Americans age 48 to 68.
Doctors can now cure about 70 percent of hepatitis C cases, but the drugs’ side effects can be severe. And many Americans are still left with a disease that can cause liver failure and cancer.
So doctors have been desperate for better treatment options.
One of the drugs in the pipeline, called miravirsen, may be able to stop the virus with little side effects, doctors from University Health Network in Toronto, Canada, reported Wednesday.
Their findings, published in The New England Journal of Medicine, are preliminary — the doctors gave the drug to just 27 patients for about a month. (Another 9 patients in the study were given a placebo.) But the study is still drawing attention because it offers proof-of-concept for a whole new class of drugs, called RNA interference drugs.
Continue reading this entire article:
http://www.npr.org/blogs/health/2013/03/27/175462370/sponge-drug-shows-promise-for-treating-hepatitis-c
